Skip to content
CityAM
Main navigation
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • Canada BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      The next person to shop your store may not be a person at all

      AI shopping agents are rewriting the rules of online retail across North America

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
    • From our partners
      • The Morning Briefing: SBS x CityAM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Cohere's Aidan Gomez bets the house on 'sovereign AI' with Aleph Alpha merger valuing the group at $20bn

      Cohere CEO Aidan Gomez on stage discussing the Toronto AI lab's strategy

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      Moonvalley's Naeem Talukdar is selling Hollywood the one thing rival AI video tools cannot: legal cover

      Moonvalley's Marey AI video model produces Hollywood-grade footage trained on licensed data

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Latest Paper
Thursday 17 April 2025 4:20 pm

Can Impax bounce back?

By: Elliot Gulliver-Needham

Add as a preferred source on Google
A&O Shearman’s £2m PEP lags behind competitors
A&O Shearman’s £2m PEP lags behind competitors

Today, Impax Asset Management entered into an agreement with European giant BNP Paribas, where the asset manager will provide investment advisory services for one of its funds.

But after hitting its lowest stock price in eight years earlier this month, analysts are split on whether Impax Asset Management will be able to bounce back.

Impax’s stock price has fallen almost 90 per cent in the last three years [to 136p], as the weak performance of the sustainable assets it focuses on has greatly reduced investor appetite for its funds.

Over the last three years, the AIM-listed fundhouse has seen assets under management plummet from £40.1bn to just £23.5bn.

However, today’s announcement has given hope that the asset manager might have a path back towards success.

Impax’s stock price is up 13 per cent since its low earlier this month, when it issued a profit warning due to a sharp decline in assets from losing St James’s Place as a key customer.

“I believe any of the asset managers, including Impax Asset Management has scope to bounce back,” said Jens Ehrenberg, senior equity research analyst at Investec.

Read more

Northern Trust Asset Management Announces Adaptive Equity Funds

“We are currently in a situation that sees both cyclical and structural challenges for the asset managers, which Impax clearly has not been immune to.”

However, the analyst noted that Impax still had a material global distribution network, and the BNP relationship may be evidence that there is potential to turn investor sentiment around.

“I see Impax as a specialist asset manager that is challenged by the cyclical backdrop as well as relatively less interest in ESG/sustainability-focused investment products but that has the potential to recover and prove its differentiation as the cycle turns going forward,” added Ehrenberg.

Investec are currently projecting that Impax’s revenue will fall from £138.2m this year to £123.7m next year, before bouncing back to £134.5m in 2027.

But Ben Yearsley, director at Fairview Investing, was more pessimistic, arguing that like most UK listed asset managers, Impax was “in the doldrums with no real sign of getting out”.

“Someone needs to come in and mop up virtually the whole listed asset management sector,” he added.

Read more

CMI Financial Group Secures Senior Financing from Royal London Asset Management

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

People & Organisations

  • BNP Paribas
  • Impax
  • Impax Asset Management
  • Investec
  • SJP
  • St James's Place

Trending Articles

  • London Tech Week sums up everything wrong with UK tech

  • Inflation expectations at record high in interest rates signal

  • KPMG’s Summer Friday half-day rollback signals deeper woes for Big Four giants

  • UK economy falters as deeper damage to growth to come

  • New Gluten-Free Bread Binder Simplifies the Recipe — and Boosts Bread Quality

More from CityAM

  • Northern Trust Asset Management Announces Adaptive Equity Funds

    Business Wire
  • CMI Financial Group Secures Senior Financing from Royal London Asset Management

    Business Wire
  • ZayZoon, the Calgary fintech born on a fishing boat, posts 1,487% growth as earned wage access goes mainstream

    ZayZoon co-founder Tate Hackert built the Calgary fintech around earned wage access
  • Northern Trust Supports Launch of Europe’s First Autocallable ETF on Waystone’s ETF ICAV platform

    Business Wire
  • Botpress raises $25m as Quebec's Sylvain Perron pitches his startup as the 'infrastructure layer' for AI agents

    Botpress product UI: the Quebec startup pitches itself as the infrastructure layer for enterprise AI agents
  • Netmore Announces Strategic Collaboration with Green Frog Asset Management and Sensational Systems to Deliver Smart Gas Metering Solution

    Business Wire
  • Royal London Asset Management Expands Relationship with SS&C to Service New Australian Funds

    Business Wire
  • FluidAI wins US FDA clearance for its surgical monitor as Waterloo's Youssef Helwa targets 100,000 operations

    FluidAI's Origin surgical monitor wins FDA clearance for use in US hospitals
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • News
  • Markets & Economics
  • Politics
  • Opinion
  • Life&Style
  • Personal Finance

Follow us for breaking news and latest updates

  • Facebook
  • X
  • Instagram
  • LinkedIn
Copyright 2026 CityAM Limited